Quest Diagnostics (DGX) PT Raised to $197 at Baird
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $244.39 +1.28%
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Baird analyst Eric Coldwell raised the price target on Quest Diagnostics (NYSE: DGX) to $197.00 (from $194.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Stella International Holdings (1836:HK) (SLNLF) PT Lowered to HK$10 at Macquarie
- WHOOP Makes Advanced Labs Available Without a Wearable Membership
- Kuaishou Technology (1024:HK) PT Lowered to HK$27.60 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
